Item Type | Name |
Concept
|
Blood Pressure
|
Concept
|
Aging
|
Concept
|
Amino Acid Sequence
|
Concept
|
Allosteric Regulation
|
Concept
|
Cell Communication
|
Concept
|
Base Sequence
|
Concept
|
Cell Differentiation
|
Concept
|
Cell Movement
|
Concept
|
Binding Sites
|
Concept
|
Cell Division
|
Concept
|
Cell Adhesion
|
Concept
|
Cell Cycle
|
Concept
|
Chemotaxis
|
Concept
|
Chicago
|
Concept
|
Codon
|
Concept
|
Gastrointestinal Neoplasms
|
Concept
|
Genital Neoplasms, Female
|
Concept
|
DNA-Binding Proteins
|
Concept
|
Drug Synergism
|
Concept
|
Cytotoxicity, Immunologic
|
Concept
|
Chemotaxis, Leukocyte
|
Concept
|
Electrophoresis, Polyacrylamide Gel
|
Concept
|
Glycerol
|
Concept
|
Drug Interactions
|
Concept
|
Endocytosis
|
Concept
|
Enzyme Activation
|
Concept
|
Gene Expression Regulation
|
Concept
|
Genes, Dominant
|
Concept
|
Glioma
|
Concept
|
Guanosine Triphosphate
|
Concept
|
Obesity
|
Concept
|
Genetic Engineering
|
Concept
|
Gonadotropins
|
Concept
|
Health Planning Guidelines
|
Concept
|
Dose-Response Relationship, Drug
|
Concept
|
Hungary
|
Concept
|
Energy Metabolism
|
Concept
|
Enzyme Induction
|
Concept
|
Membrane Glycoproteins
|
Concept
|
Gonadotropin-Releasing Hormone
|
Concept
|
Microfilament Proteins
|
Concept
|
Pregnancy
|
Concept
|
Immunocompetence
|
Concept
|
Molecular Sequence Data
|
Concept
|
Molecular Weight
|
Concept
|
Glycogen
|
Concept
|
Glycolysis
|
Concept
|
Mutation
|
Concept
|
Stimulation, Chemical
|
Concept
|
Phosphorylation
|
Concept
|
Plasminogen Activators
|
Concept
|
Protein Precursors
|
Concept
|
Protein-Tyrosine Kinases
|
Concept
|
Protein Binding
|
Concept
|
Proto-Oncogene Proteins
|
Concept
|
Pseudogenes
|
Concept
|
Proteins
|
Concept
|
Gastrins
|
Concept
|
Repressor Proteins
|
Concept
|
Protein Kinases
|
Concept
|
Sequence Homology, Nucleic Acid
|
Concept
|
Genes, ras
|
Concept
|
Regulatory Sequences, Nucleic Acid
|
Concept
|
RNA Splicing
|
Concept
|
Solubility
|
Concept
|
RNA Processing, Post-Transcriptional
|
Concept
|
Sensitivity and Specificity
|
Concept
|
Time Factors
|
Concept
|
Transcription, Genetic
|
Concept
|
Protein Biosynthesis
|
Concept
|
Proto-Oncogene Proteins pp60(c-src)
|
Concept
|
Hepatocyte Growth Factor
|
Concept
|
Sequence Homology, Amino Acid
|
Concept
|
Plasminogen Activator Inhibitor 1
|
Concept
|
Ultraviolet Rays
|
Concept
|
Urokinase-Type Plasminogen Activator
|
Concept
|
Phosphotransferases (Alcohol Group Acceptor)
|
Concept
|
Germ-Line Mutation
|
Concept
|
Geriatric Assessment
|
Concept
|
Oncogene Proteins
|
Concept
|
Trans-Activators
|
Concept
|
Drug Resistance, Neoplasm
|
Concept
|
Guanine Nucleotide Exchange Factors
|
Concept
|
rho GTP-Binding Proteins
|
Concept
|
rac1 GTP-Binding Protein
|
Concept
|
Mitogen-Activated Protein Kinases
|
Concept
|
Transforming Growth Factor beta
|
Concept
|
Extracellular Matrix Proteins
|
Concept
|
Genes, BRCA2
|
Concept
|
HMGA2 Protein
|
Concept
|
Up-Regulation
|
Concept
|
Genes, Tumor Suppressor
|
Concept
|
Mutagenesis
|
Concept
|
Genes, jun
|
Concept
|
Proto-Oncogene Proteins c-fos
|
Concept
|
Gene Expression
|
Concept
|
Proto-Oncogene Proteins c-myc
|
Concept
|
RNA Interference
|
Concept
|
Protein Structure, Tertiary
|
Concept
|
Postmenopause
|
Concept
|
Methylation
|
Concept
|
Genes, Reporter
|
Concept
|
Genomic Instability
|
Concept
|
RNA-Binding Proteins
|
Concept
|
Immediate-Early Proteins
|
Concept
|
Gelatinases
|
Concept
|
Apoptosis
|
Concept
|
Sequence Deletion
|
Concept
|
Cell Proliferation
|
Concept
|
Vesicular Monoamine Transport Proteins
|
Concept
|
Oxidative Stress
|
Concept
|
ras Proteins
|
Concept
|
BRCA1 Protein
|
Concept
|
Fas Ligand Protein
|
Concept
|
Receptor Protein-Tyrosine Kinases
|
Concept
|
Protein Transport
|
Concept
|
Multidrug Resistance-Associated Proteins
|
Concept
|
Protein Tyrosine Phosphatases
|
Concept
|
Pentose Phosphate Pathway
|
Concept
|
Metabolome
|
Concept
|
Vascular Endothelial Growth Factor Receptor-2
|
Concept
|
Mitogen-Activated Protein Kinase 8
|
Concept
|
Green Fluorescent Proteins
|
Concept
|
Vascular Endothelial Growth Factors
|
Concept
|
Mitogen-Activated Protein Kinase 3
|
Concept
|
Sex Cord-Gonadal Stromal Tumors
|
Concept
|
Paracrine Communication
|
Concept
|
Proto-Oncogene Proteins c-raf
|
Concept
|
Cell Growth Processes
|
Concept
|
Cell Cycle Proteins
|
Concept
|
Proto-Oncogene Proteins c-kit
|
Concept
|
rac GTP-Binding Proteins
|
Concept
|
Receptor, Platelet-Derived Growth Factor alpha
|
Concept
|
Mitogen-Activated Protein Kinase Kinases
|
Concept
|
Genes, BRCA1
|
Concept
|
Gene Expression Profiling
|
Concept
|
BRCA2 Protein
|
Concept
|
Wnt Proteins
|
Concept
|
Polyethylene Glycols
|
Concept
|
Animals, Genetically Modified
|
Concept
|
Gestational Trophoblastic Disease
|
Concept
|
Promoter Regions, Genetic
|
Concept
|
Focal Adhesion Protein-Tyrosine Kinases
|
Concept
|
Receptors, Glucocorticoid
|
Concept
|
Recombinant Proteins
|
Concept
|
Transforming Growth Factor beta1
|
Concept
|
Transforming Growth Factor beta2
|
Concept
|
Protein Phosphatase 1
|
Concept
|
Suppression, Genetic
|
Concept
|
Receptors, Vascular Endothelial Growth Factor
|
Concept
|
Fatty Acid-Binding Proteins
|
Concept
|
Proteolysis
|
Concept
|
Substrate Specificity
|
Concept
|
Down-Regulation
|
Concept
|
Proto-Oncogene Proteins c-jun
|
Concept
|
Cell Death
|
Concept
|
Transfection
|
Concept
|
Platelet Activation
|
Concept
|
Cell Hypoxia
|
Concept
|
Genome, Human
|
Concept
|
Gene Expression Regulation, Enzymologic
|
Concept
|
Retinoblastoma Protein
|
Concept
|
Fibroblast Growth Factor 1
|
Concept
|
Proto-Oncogene Proteins p21(ras)
|
Concept
|
DNA Methylation
|
Concept
|
Metabolic Networks and Pathways
|
Concept
|
Proto-Oncogene Proteins c-met
|
Concept
|
Mitogen-Activated Protein Kinase 1
|
Concept
|
Calcium-Calmodulin-Dependent Protein Kinases
|
Concept
|
Receptor Cross-Talk
|
Concept
|
Anoikis
|
Concept
|
Gene Knockdown Techniques
|
Concept
|
Homeodomain Proteins
|
Concept
|
Genes, erbB-2
|
Concept
|
Cell Lineage
|
Concept
|
Gadolinium DTPA
|
Concept
|
Inhibitory Concentration 50
|
Concept
|
MAP Kinase Signaling System
|
Concept
|
JNK Mitogen-Activated Protein Kinases
|
Concept
|
Vesicular Biogenic Amine Transport Proteins
|
Concept
|
Cell Cycle Checkpoints
|
Concept
|
Transcriptome
|
Concept
|
Tumor Microenvironment
|
Concept
|
Vascular Endothelial Growth Factor A
|
Concept
|
Homologous Recombination
|
Concept
|
Cell Shape
|
Concept
|
Lipid Metabolism
|
Concept
|
Receptors, Urokinase Plasminogen Activator
|
Concept
|
Wnt Signaling Pathway
|
Concept
|
Neoplasm Grading
|
Concept
|
Carrier Proteins
|
Concept
|
Cell Survival
|
Concept
|
Chromatin
|
Concept
|
Genetic Testing
|
Concept
|
Glucose
|
Concept
|
Guanosine Diphosphate
|
Concept
|
Luminescent Proteins
|
Concept
|
Neoplasm Proteins
|
Concept
|
Neoplasms, Glandular and Epithelial
|
Concept
|
Nuclear Proteins
|
Concept
|
Embryo Implantation
|
Concept
|
Phenotype
|
Concept
|
Phylogeny
|
Concept
|
Platelet Membrane Glycoproteins
|
Concept
|
Surface Properties
|
Concept
|
Translocation, Genetic
|
Concept
|
Signal Transduction
|
Concept
|
Transcriptional Activation
|
Concept
|
Gene Expression Regulation, Neoplastic
|
Concept
|
Tumor Suppressor Protein p53
|
Concept
|
Genes, Neurofibromatosis 1
|
Concept
|
Oncogene Proteins v-fos
|
Concept
|
Gonadoblastoma
|
Concept
|
Genetic Predisposition to Disease
|
Concept
|
Protein Isoforms
|
Concept
|
Polymorphism, Single Nucleotide
|
Concept
|
Receptor, Platelet-Derived Growth Factor beta
|
Concept
|
Genomics
|
Concept
|
Membrane Transport Proteins
|
Concept
|
Protein Array Analysis
|
Concept
|
Eosinophil Cationic Protein
|
Concept
|
Protein Kinase Inhibitors
|
Concept
|
p38 Mitogen-Activated Protein Kinases
|
Concept
|
Proto-Oncogene Proteins c-akt
|
Academic Article
|
Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line.
|
Academic Article
|
Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator receptor gene.
|
Academic Article
|
In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid.
|
Academic Article
|
Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer.
|
Academic Article
|
Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor.
|
Academic Article
|
Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
|
Academic Article
|
Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.
|
Academic Article
|
[The clinical importance of keratin 18 in breast cancer].
|
Academic Article
|
beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter.
|
Academic Article
|
Integrin alpha(v)beta(3)/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells.
|
Academic Article
|
Gastrin induces expression and promoter activity of the vesicular monoamine transporter subtype 2.
|
Academic Article
|
UVB increases urokinase-type plasminogen activator receptor (uPAR) expression.
|
Academic Article
|
JNK and p38MAPK are activated during graft reperfusion and not during cold storage in rat liver transplantation.
|
Academic Article
|
Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b.
|
Academic Article
|
Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia.
|
Academic Article
|
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
|
Academic Article
|
Tumor-specific transcription factor binding to an activator protein-2/Sp1 element of the urokinase-type plasminogen activator receptor promoter in a first large series of resected gastrointestinal cancers.
|
Academic Article
|
Role of beta(3)-endonexin in the regulation of NF-kappaB-dependent expression of urokinase-type plasminogen activator receptor.
|
Academic Article
|
Ras regulation of urokinase-type plasminogen activator.
|
Academic Article
|
Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
|
Academic Article
|
Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation.
|
Academic Article
|
Isolation and characterization of Rac1 pseudogenes (psi1Rac1-psi4Rac1) in the human genome.
|
Academic Article
|
PDGFR-alpha as a potential therapeutic target in uterine sarcomas.
|
Academic Article
|
Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia.
|
Academic Article
|
Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2.
|
Academic Article
|
C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu.
|
Academic Article
|
Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer.
|
Academic Article
|
Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer.
|
Academic Article
|
Reversible posterior leukoencephalopathy syndrome following intravenous paclitaxel and intraperitoneal cisplatin chemotherapy for fallopian tube cancer.
|
Academic Article
|
Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and beta1-integrin on the cell surface.
|
Academic Article
|
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.
|
Academic Article
|
An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis.
|
Academic Article
|
MMP-2 functions as an early response protein in ovarian cancer metastasis.
|
Academic Article
|
Combination analysis of activator protein-1 family members, Sp1 and an activator protein-2alpha-related factor binding to different regions of the urokinase receptor gene in resected colorectal cancers.
|
Academic Article
|
Effects of oral contraceptives or a gonadotropin-releasing hormone agonist on ovarian carcinogenesis in genetically engineered mice.
|
Academic Article
|
CD95 promotes tumour growth.
|
Academic Article
|
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion.
|
Academic Article
|
A phase II, single-arm study of the anti-a5ß1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer.
|
Academic Article
|
Let-7 expression defines two differentiation stages of cancer.
|
Academic Article
|
RFLP Molecular Analysis of the Urokinase-Type Plasminogen Activator Gene.
|
Academic Article
|
Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1.
|
Academic Article
|
Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.
|
Academic Article
|
Ligand-independent activation of c-Met by fibronectin and a(5)ß(1)-integrin regulates ovarian cancer invasion and metastasis.
|
Academic Article
|
Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis.
|
Academic Article
|
The Müllerian HOXA10 gene promotes growth of ovarian surface epithelial cells by stimulating epithelial-stromal interactions.
|
Academic Article
|
FOXL2 and SOX9 distinguish the lineage of the sex cord-stromal cells in gonadoblastomas.
|
Academic Article
|
A special key for unlocking the door to targeted therapies of breast cancer.
|
Academic Article
|
The effects of 17ß-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis.
|
Academic Article
|
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.
|
Academic Article
|
Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis.
|
Academic Article
|
Acute inflammatory reaction following placement of sodium hyaluronate-carboxymethylcellulose barrier in a young woman undergoing gynecologic surgery: a case report.
|
Academic Article
|
Rethinking ovarian cancer: recommendations for improving outcomes.
|
Academic Article
|
Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure.
|
Academic Article
|
Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras.
|
Academic Article
|
Up-regulation of urokinase-type plasminogen activator expression by the HER2/neu proto-oncogene.
|
Academic Article
|
Tyrosine kinase mutations in human cancer.
|
Academic Article
|
Keratin expression reveals mosaic differentiation in vaginal epithelium.
|
Academic Article
|
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
|
Academic Article
|
Stimulation of urokinase expression by TNF-alpha requires the activation of binding sites for the AP-1 and PEA3 transcription factors.
|
Academic Article
|
The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer.
|
Academic Article
|
Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences.
|
Academic Article
|
The expression of hepatocyte growth factor (HGF) and c-Met in uterine serous carcinoma.
|
Academic Article
|
HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts.
|
Academic Article
|
Transient interaction of activated platelets with endothelial cells induces expression of monocyte-chemoattractant protein-1 via a p38 mitogen-activated protein kinase mediated pathway. Implications for atherogenesis.
|
Academic Article
|
Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue.
|
Academic Article
|
A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings.
|
Academic Article
|
Up-regulation of alpha5-integrin by E-cadherin loss in hypoxia and its key role in the migration of extravillous trophoblast cells during early implantation.
|
Academic Article
|
Rac1 and Rho contribute to the migratory and invasive phenotype associated with somatic E-cadherin mutation.
|
Academic Article
|
Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity.
|
Academic Article
|
miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin a5 expression.
|
Academic Article
|
Serial sectioning of the fallopian tube allows for improved identification of primary fallopian tube carcinoma.
|
Academic Article
|
MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer.
|
Academic Article
|
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
|
Academic Article
|
Expression of the homeobox gene HOXA9 in ovarian cancer induces peritoneal macrophages to acquire an M2 tumor-promoting phenotype.
|
Academic Article
|
Utility of routine surveillance methods in detecting recurrence in high grade endometrial cancer patients.
|
Academic Article
|
Three-dimensional modeling of ovarian cancer.
|
Academic Article
|
Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy.
|
Academic Article
|
Epithelial ovarian cancer experimental models.
|
Academic Article
|
WNT7A/ß-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer.
|
Academic Article
|
Summary of the 2013 American Association for Cancer Research (AACR) Annual Meeting.
|
Academic Article
|
Old drug, new trick: repurposing metformin for gynecologic cancers?
|
Academic Article
|
Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models.
|
Academic Article
|
Whole-genome characterization of chemoresistant ovarian cancer.
|
Academic Article
|
Patterns and utility of routine surveillance in high grade endometrial cancer.
|
Academic Article
|
The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
|
Academic Article
|
Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma.
|
Academic Article
|
Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer.
|
Academic Article
|
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer.
|
Academic Article
|
MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment.
|
Academic Article
|
Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis.
|
Academic Article
|
Corrigendum: Whole-genome characterization of chemoresistant ovarian cancer.
|
Academic Article
|
Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.
|
Academic Article
|
A prospective study evaluating diffusion weighted magnetic resonance imaging (DW-MRI) in the detection of peritoneal carcinomatosis in suspected gynecologic malignancies.
|
Academic Article
|
Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status.
|
Academic Article
|
Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers.
|
Academic Article
|
Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells.
|
Academic Article
|
Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform.
|
Academic Article
|
Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube.
|
Academic Article
|
Gastrin Induces Expression and Promoter Activity of the Vesicular Monoamine Transporter Subtype 2.
|
Academic Article
|
Prolactin Receptor-Mediated Internalization of Imaging Agents Detects Epithelial Ovarian Cancer with Enhanced Sensitivity and Specificity.
|
Academic Article
|
Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention.
|
Academic Article
|
A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth.
|
Academic Article
|
High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer.
|
Academic Article
|
Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer.
|
Academic Article
|
Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor-Engineered T Cells for Ovarian Cancer.
|
Academic Article
|
A 3D tumor microenvironment regulates cell proliferation, peritoneal growth and expression patterns.
|
Academic Article
|
Who are the long-term survivors of high grade serous ovarian cancer?
|
Academic Article
|
Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis.
|
Academic Article
|
m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer.
|
Academic Article
|
The road to long-term survival: Surgical approach and longitudinal treatments of long-term survivors of advanced-stage serous ovarian cancer.
|
Academic Article
|
Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis.
|
Academic Article
|
Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum.
|
Academic Article
|
SPHK1 Is a Novel Target of Metformin in Ovarian Cancer.
|
Academic Article
|
Interpretation of Mismatch Repair Protein Immunohistochemistry in Endometrial Carcinoma Should Consider Both Lynch Syndrome Screening and Immunotherapy Susceptibility: An Illustrative Case Report.
|
Academic Article
|
Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis.
|
Academic Article
|
Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6.
|
Academic Article
|
New Roles for Glycogen in Tumor Progression.
|
Academic Article
|
Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake.
|
Academic Article
|
RADAR: differential analysis of MeRIP-seq data with a random effect model.
|
Academic Article
|
Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.
|
Academic Article
|
Complete Response in a Patient With Chemorefractory EGFR-Amplified, PD-L1-Positive Metastatic Gastric Cancer Treated By Dual Anti-EGFR and Anti-PD-1 Monoclonal Antibody Therapy.
|
Academic Article
|
Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment.
|
Academic Article
|
Twenty-year longitudinal study on aged people in Budapest.
|
Academic Article
|
Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis.
|
Academic Article
|
Germline mutations in Black patients with ovarian, fallopian tube and primary peritoneal carcinomas.
|
Academic Article
|
Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian Cancer.
|
Academic Article
|
High glucocorticoid receptor expression in the sarcomatous versus carcinomatous elements of Mullerian carcinosarcomas.
|
Academic Article
|
Molecular Characterizations of Gynecologic Carcinosarcomas: A Focus on the Immune Microenvironment.
|
Academic Article
|
A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencing.
|
Academic Article
|
Cancer-associated mesothelial cell-derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis.
|
Concept
|
MutL Protein Homolog 1
|
Concept
|
Protein Domains
|
Concept
|
Forkhead Box Protein L2
|
Concept
|
T-Lymphoma Invasion and Metastasis-inducing Protein 1
|
Concept
|
Clustered Regularly Interspaced Short Palindromic Repeats
|
Academic Article
|
The glycoprotein CD147 defines miRNA-enriched extracellular vesicles that derive from cancer cells.
|
Academic Article
|
Adipocytes reprogram cancer cell metabolism by diverting glucose towards glycerol-3-phosphate thereby promoting metastasis.
|
Academic Article
|
5-Hydroxymethylcytosine signals in serum are a predictor of chemoresistance in high-grade serous ovarian cancer.
|